Voluntary Health Associations & Medical Disciplines
Ecog-Acrin Medical Research Foundation Inc
PHILADELPHIA, PA
Total revenue
$53.3M
Total expenses
$53.5M
Net assets
$6.3M
Grants received
$3.5M
12 grants
EIN
460745339
Tax year
2024
Mission
The purpose of ecog-acrin medical research foundation, inc. Is to foster clinical research within the public, non-profit and private sectors for the detection, diagnosis, prevention and treatment of cancer and other related diseases, including through developing technology to predict prognosis and responses to therapeutic intervention for patients with cancer and other related diseases, that will ultimately improve the outcomes for cancer patients.
Programs
3 programs
Pharmaceutical grants through supplemental funding on nci approved and funded trials, ecog-acrin medical research foundation inc. Carries out activities described in the scope of functions of each nci protocol. All functions are performed in compliance with federal, state and local laws, with an overarching goal of reaching full accruals to further advance the research and medicine aimed at improving outcomes for cancer patients.
Federal contracts the ecog-acrin medical research foundation inc., through its subrecipient federal contract funding for the nci match and mds programs aids ecog-acrin in providing the support necessary to conduct specific relevant and rigorous clinical trials, which aim to benefit the public health by improving the quantity and standard of care for cancer patients.
Other program services industry payments the ecog-acrin medical research foundation inc. Also receives funding on behalf of other nci-funded cancer cooperative groups in support of efforts taken by individual sites that are credited as ecog-acrin institutions aligned with the mission to improve the outcomes for cancer patients. This and other funding is primarily pass-through payments from other groups and is passed along to the ecog-acrin credited sites. These funds are used by institutions to continue their collective efforts of conducting relevant and rigorous clinical trials, which aim to benefit public health by improving the quantity and standard of care for cancer patients.
Financials
FY 2024
Revenue
Expenses
People
12 listed
DONNA MARINUCCI
EXECUTIVE DI
$305K
40 hrs/wk
MITCHELL SCHNALL MD PHD
SECRETARY/TR
—
4 hrs/wk
DANIEL BARBORIAK MD
BOARD MEMBER
—
PETER O'DWYER MD
PRESIDENT
—
15 hrs/wk
AL BOWEN BENSON MD
BOARD MEMBER
—
PATRICK FLYNN MD
BOARD MEMBER
—
STANLEY M HAMILTON MD
BOARD MEMBER
—
BARRY A SIEGEL MD
BOARD MEMBER
—
JEAN MACDONALD
DEPUTY EXEC
$272K
40 hrs/wk
KENNETH ROCKWELL
DIR REGULATO
$222K
40 hrs/wk
KERRY HIGGINS
DIRECTOR DAT
$214K
40 hrs/wk
PAMELA COGLIANO
DIRECTOR OF
$199K
40 hrs/wk
Independent contractors
COALITION OF CANCER COOPERATIVE GRPS
SALARY SUPPORT
Grants received
Showing 12 of 12
Funded by
$3.5M from 6 funders · 12 grants · 2017–2024
$1.4M · 4 grants · 2020–2024
$994K · 1 grant · 2017
$675K · 3 grants · 2021–2023
$258K · 1 grant · 2023
$65K · 2 grants · 2023–2024
$40K · 1 grant · 2024